| BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 卷:1802 |
| Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation | |
| Article | |
| Banerjee, Sanjay K.1  McGaffin, Kenneth R.1  Huang, Xueyin N.1  Ahmad, Ferhaan1,2  | |
| [1] Univ Pittsburgh, Cardiovasc Inst, Dept Med, Pittsburgh, PA 15213 USA | |
| [2] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA | |
| 关键词: AMPK; Hypertrophy; AKT; NF-kappa B; Transgenic Mouse; Heart; | |
| DOI : 10.1016/j.bbadis.2009.12.001 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Human mutations in PRKAG2, the gene encoding the gamma 2 subunit of AMP activated protein kinase (AMPK), cause a glycogen storage cardiomyopathy. In a transgenic mouse with cardiac specific expression of the Thr400Asn mutation in PRKAG2 (TG(T400N)), we previously reported initial cardiac hypertrophy (ages 28 weeks) followed by dilation and failure (ages 12-20 weeks). We sought to elucidate the molecular mechanisms of cardiac hypertrophy. TG(T400N) Mice showed significantly increased cardiac mass/body mass ratios up to similar to 3-fold beginning at age 2 weeks. Cardiac expression of ANP and BNP were similar to 2- and similar to 5-fold higher, respectively, in TG(T400N) relative to wildtype (WT) mice at age 2 weeks. NF-kappa B activity and nuclear translocation of the p50 subunit were increased similar to 2- to 3-fold in TG(T400N) hearts relative to WT during the hypertrophic phase. Phosphorylated Akt and p70S6K were elevated similar to 2-fold as early as age 2 weeks. To ascertain whether these changes in TG(T400N) Mice were a consequence of increased AMPK activity, we crossbred TG(T400N) with TG(alpha 2DN) mice, which express a dominant negative, kinase dead mutant of the AMPK alpha 2 catalytic subunit and have low myocardial AMPK activity. Genetic reversal of AMPK overactivity led to a reduction in hypertrophy, nuclear translocation of NF-kappa B, phosphorylated Akt, and p70S6K. We conclude that inappropriate activation of AMPK secondary to the T400N PRKAG2 mutation is associated with the early activation of NF-kappa B and Akt signaling pathway, which mediates cardiac hypertrophy. (C) 2009 Elsevier B.V. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_bbadis_2009_12_001.pdf | 991KB |
PDF